Linking T cells to Alzheimer's disease: From neurodegeneration to neurorepair

Current Opinion in Pharmacology

Volumn 26, Issue , 2016, Pages 67-73

  Bryson, Karen J ^a   Lynch, Marina A ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE VACCINE; AMYLOID BETA PROTEIN; FLAVONOID; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 17; INTERLEUKIN 18; INTERLEUKIN 21; INTERLEUKIN 22; INTERLEUKIN 6; INTERLEUKIN 9; MONOCYTE CHEMOTACTIC PROTEIN 1; RUTOSIDE; SYNTHETIC PEPTIDE; TUMOR NECROSIS FACTOR ALPHA; VIRUS VECTOR;

ADAPTIVE IMMUNITY; ALZHEIMER DISEASE; ARTICLE; CD27+ T LYMPHOCYTE; CD28+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD71+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL THERAPY; CEREBROSPINAL FLUID; COGNITION; COMPARATIVE STUDY; DNA POLYMORPHISM; DRUG SAFETY; GENETIC ASSOCIATION; GLIA CELL; HUMAN; IMMUNOMODULATION; IMMUNOPATHOGENESIS; INFLAMMATION; MEMORY T LYMPHOCYTE; MILD COGNITIVE IMPAIRMENT; NERVE CELL PLASTICITY; NERVE DEGENERATION; NERVE REGENERATION; NEUROPROTECTION; NONHUMAN; PHASE 2 CLINICAL TRIAL (TOPIC); POLARIZATION; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH17 CELL; TH2 CELL; VACCINATION; VIRAL GENE DELIVERY SYSTEM; ANIMAL; BRAIN; IMMUNOLOGY;

ADAPTIVE IMMUNITY; ALZHEIMER DISEASE; ANIMALS; BRAIN; HUMANS; T-LYMPHOCYTES;

EID: 84946934978     PISSN: 14714892     EISSN: 14714973     Source Type: Journal    
DOI: 10.1016/j.coph.2015.10.003     Document Type: Review

References (67)

1. M.J. Rowan, and et al. Synaptic memory mechanisms: Alzheimer's disease amyloid beta-peptide-induced dysfunction Biochem Soc Trans 35 Pt 5 2007 1219 1223
2. D.M. Walsh, and et al. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo Nature 416 2002 535 539
3. R.S. Jones, and et al. Amyloid-beta-induced astrocytic phagocytosis is mediated by CD36, CD47 and RAGE J Neuroimmune Pharmacol 8 2013 301 311
4. A. Lyons, and et al. Dok2 mediates the CD200Fc attenuation of Abeta-induced changes in glia J Neuroinflammation 9 2012 107
5. R.M. Clarke, and et al. The HMG-CoA reductase inhibitor, atorvastatin, attenuates the effects of acute administration of amyloid-beta1-42 in the rat hippocampus in vivo Neuropharmacology 52 2007 136 145
6. J. Wang, and et al. Anti-inflammatory drugs and risk of Alzheimer's disease: an updated systematic review and meta-analysis J Alzheimers Dis 44 2015 385 396
7. J.C. Breitner, and et al. Extended results of the Alzheimer's disease anti-inflammatory prevention trial Alzheimers Dement 7 2011 402 411
8. C.A. Szekely, and P.P. Zandi Non-steroidal anti-inflammatory drugs and Alzheimer's disease: the epidemiological evidence CNS Neurol Disord Drug Targets 9 2010 132 139
9. M. Pellicano, and et al. Immune profiling of Alzheimer patients J Neuroimmunol 242 2012 52 59
10. C.M. Karch, and A.M. Goate Alzheimer's disease risk genes and mechanisms of disease pathogenesis Biol Psychiatry 77 2015 43 51
11. D. Schenk, and et al. Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse Nature 400 1999 173 177
12. G. Lueg, and et al. Clinical relevance of specific T-cell activation in the blood and cerebrospinal fluid of patients with mild Alzheimer's disease Neurobiol Aging 36 2015 81 89
13. L. Speciale, and et al. Lymphocyte subset patterns and cytokine production in Alzheimer's disease patients Neurobiol Aging 28 2007 1163 1169
14. D. Rosenkranz, and et al. Higher frequency of regulatory T cells in the elderly and increased suppressive activity in neurodegeneration J Neuroimmunol 188 2007 117 127
15. A. Larbi, and et al. Dramatic shifts in circulating CD4 but not CD8 T cell subsets in mild Alzheimer's disease J Alzheimers Dis 17 2009 91 103
16. M. Saresella, and et al. PD1 negative and PD1 positive CD4+ T regulatory cells in mild cognitive impairment and Alzheimer's disease J Alzheimers Dis 21 2010 927 938
17. F. Brosseron, and et al. Body fluid cytokine levels in mild cognitive impairment and Alzheimer's disease: a comparative overview Mol Neurobiol 50 2014 534 544
18. R.J. Bateman, and et al. Clinical and biomarker changes in dominantly inherited Alzheimer's disease N Engl J Med 367 2012 795 804
19. A. Jozwik, and et al. Beta-amyloid peptides enhance the proliferative response of activated CD4CD28 lymphocytes from Alzheimer disease patients and from healthy elderly PLoS One 7 2012 e33276
20. M. Saresella, and et al. Increased activity of Th-17 and Th-9 lymphocytes and a skewing of the post-thymic differentiation pathway are seen in Alzheimer's disease Brain Behav Immun 25 2011 539 547
21. Y.J. Liu, and et al. Peripheral T cells derived from Alzheimer's disease patients overexpress CXCR2 contributing to its transendothelial migration, which is microglial TNF-alpha-dependent Neurobiol Aging 31 2010 175 188
22. M. Reale, and et al. Peripheral chemokine receptors, their ligands, cytokines and Alzheimer's disease J Alzheimers Dis 14 2008 147 159
23. S.M. Man, and et al. Peripheral T cells overexpress MIP-1 alpha to enhance its transendothelial migration in Alzheimer's disease Neurobiol Aging 28 2007 485 496
24. M. Li, and et al. Amyloid beta interaction with receptor for advanced glycation end products up-regulates brain endothelial CCR5 expression and promotes T cells crossing the blood-brain barrier J Immunol 182 2009 5778 5788
25. M.Q. Xia, and et al. Immunohistochemical study of the beta-chemokine receptors CCR3 and CCR5 and their ligands in normal and Alzheimer's disease brains Am J Pathol 153 1998 31 37
26. Y.J. Liu T. Peripheral cells derived from Alzheimer's disease patients overexpress CXCR2 contributing to its transendothelial migration, which is microglial TNF-alpha-dependent Neurobiol Aging 31 2010 175 188
27. N.L. Monson C.N.S. Elevated inflammation in patients with preclinical Alzheimer's disease J Cereb Blood Flow Metab 34 2014 30 33
28. W.F. Hickey Basic principles of immunological surveillance of the normal central nervous system Glia 36 2001 118 124
29. K. Baruch, and et al. Aging-induced type I interferon response at the choroid plexus negatively affects brain function Science 346 2014 89 93
30. K. Baruch, and et al. Breaking immune tolerance by targeting Foxp3(+) regulatory T cells mitigates Alzheimer's disease pathology Nat Commun 6 2015 7967
31. M. Hartwig Immune ageing and Alzheimer's disease Neuroreport 6 1995 1274 1276
32. P.L. McGeer, and et al. Immune system response in Alzheimer's disease Can J Neurol Sci 16 4 Suppl. 1989 516 527
33. A. Parachikova, and et al. Inflammatory changes parallel the early stages of Alzheimer disease Neurobiol Aging 28 2007 1821 1833
34. T. Pirttila, S. Mattinen, and H. Frey The decrease of CD8-positive lymphocytes in Alzheimer's disease J Neurol Sci 107 1992 160 165
35. T. Town, and et al. T-cells in Alzheimer's disease Neuromolecular Med 7 2005 255 264
36. S. Itagaki, P.L. McGeer, and H. Akiyama Presence of T-cytotoxic suppressor and leucocyte common antigen positive cells in Alzheimer's disease brain tissue Neurosci Lett 91 1988 259 264
37. J. Rogers, and et al. Expression of immune system-associated antigens by cells of the human central nervous system: relationship to the pathology of Alzheimer's disease Neurobiol Aging 9 1988 339 349
38. T. Togo, and et al. Occurrence of T cells in the brain of Alzheimer's disease and other neurological diseases J Neuroimmunol 124 2002 83 92
39. F. Sardi, and et al. Alzheimer's disease, autoimmunity and inflammation. The good, the bad and the ugly Autoimmun Rev 11 2011 149 153
40. F.L. Heppner, R.M. Ransohoff, and B. Becher Immune attack: the role of inflammation in Alzheimer disease Nat Rev Neurosci 16 2015 358 372
41. G. Kunis, and et al. IFN-gamma-dependent activation of the brain's choroid plexus for CNS immune surveillance and repair Brain 136 Pt 11 2013 3427 3440
42. K. Baruch, and et al. Cerebral nitric oxide represses choroid plexus NFkappaB-dependent gateway activity for leukocyte trafficking EMBO J 34 2015 1816 1828
43. T.C. Browne, and et al. IFN-gamma Production by amyloid beta-specific Th1 cells promotes microglial activation and increases plaque burden in a mouse model of Alzheimer's disease J Immunol 190 2013 2241 2251
44. A.M. Minogue, and et al. Age-associated dysregulation of microglial activation is coupled with enhanced blood-brain barrier permeability and pathology in APP/PS1 mice Neurobiol Aging 35 2014 1442 1452
45. R.J. Kelly, and et al. Glial activation in A beta PP/PS1 mice is associated with infiltration of IFN gamma-Producing Cells J Alzheimers Dis 37 2013 63 75
46. A.K. Stalder, and et al. Invasion of hematopoietic cells into the brain of amyloid precursor protein transgenic mice J Neurosci 25 2005 11125 11132
47. R.M. McManus, and et al. Respiratory infection promotes T cell infiltration and amyloid-beta deposition in APP/PS1 mice Neurobiol Aging 35 2014 109 121
48. J. Zhang, and et al. Th17 cell-mediated neuroinflammation is involved in neurodegeneration of abeta1-42-induced Alzheimer's disease model rats PLoS One 8 2013 e75786
49. D. Lambracht-Washington, and et al. DNA immunization against amyloid beta 42 has high potential as safe therapy for Alzheimer's disease as it diminishes antigen-specific Th1 and Th17 cell proliferation Cell Mol Neurobiol 31 2011 867 874
50. S. Liu, and et al. Co-immunization with DNA and protein mixture: a safe and efficacious immunotherapeutic strategy for Alzheimer's disease in PDAPP mice Sci Rep 5 2015 7771
51. H.J. Fu, and et al. Amyloid-beta immunotherapy for Alzheimer's disease CNS Neurol Disord Drug Targets 9 2010 197 206
52. D. Lambracht-Washington, and R.N. Rosenberg Co-stimulation with TNF receptor superfamily 4/25 antibodies enhances in-vivo expansion of CD4+CD25+Foxp3+ T cells (Tregs) in a mouse study for active DNA Abeta42 immunotherapy J Neuroimmunol 278c 2015 90 99
53. Y. Fisher, and et al. Th1 polarization of T cells injected into the cerebrospinal fluid induces brain immunosurveillance J Immunol 192 2014 92 102
54. C. Cao, and et al. Abeta-specific Th2 cells provide cognitive and pathological benefits to Alzheimer's mice without infiltrating the CNS Neurobiol Dis 34 2009 63 70
55. S.P. Gadani, and et al. IL-4 in the brain: a cytokine to remember J Immunol 189 2012 4213 4219
56. Y. Nolan, and et al. Role of interleukin-4 in regulation of age-related inflammatory changes in the hippocampus J Biol Chem 280 2005 9354 9362
57. A.A. Asuni, and et al. Vaccination of Alzheimer's model mice with Abeta derivative in alum adjuvant reduces Abeta burden without microhemorrhages Eur J Neurosci 24 2006 2530 2542
58. H.L. Weiner, and et al. Nasal administration of amyloid-beta peptide decreases cerebral amyloid burden in a mouse model of Alzheimer's disease Ann Neurol 48 2000 567 579
59. K. Baruch, and et al. CNS-specific immunity at the choroid plexus shifts toward destructive Th2 inflammation in brain aging Proc Natl Acad Sci U S A 110 2013 2264 2269
60. P. Chakrabarty, and et al. Hippocampal expression of murine IL-4 results in exacerbation of amyloid deposition Mol Neurodeg 7 2012 36
61. P. Chakrabarty, and et al. IL-10 alters immunoproteostasis in APP mice, increasing plaque burden and worsening cognitive behavior Neuron 85 2015 519 533
62. M.V. Guillot-Sestier, and et al. Il10 deficiency rebalances innate immunity to mitigate Alzheimer-like pathology Neuron 85 2015 534 548
63. L. Xie, and et al. Cerebral regulatory T cells restrain microglia/macrophage-mediated inflammatory responses via IL-10 Eur J Immunol 45 2015 180 191
64. H. Yang, and et al. Systemic transplantation of human umbilical cord derived mesenchymal stem cells-educated T regulatory cells improved the impaired cognition in AbetaPPswe/PS1dE9 transgenic mice PLoS One 8 2013 e69129
65. J. Kipnis, and et al. Dual effect of CD4+CD25+ regulatory T cells in neurodegeneration: a dialogue with microglia Proc Natl Acad Sci U S A 101 Suppl. 2 2004 14663 14669
66. C. Raposo, and et al. CNS repair requires both effector and regulatory T cells with distinct temporal and spatial profiles J Neurosci 34 2014 10141 10155
67. L.S. Dungan, and et al. Innate IFN-gamma promotes development of experimental autoimmune encephalomyelitis: a role for NK cells and M1 macrophages Eur J Immunol 44 2014 2903 2917